Impaired cholinergic neurotransmission is recognized as a major pathological mechanism that contributes to cognitive decline [8], with alterations in the expression of ChAT and AChE serving as key molecular indicators that reflect reduced synaptic plasticity and behavioral deficits [8]. The gene discussed is ACHE; the disease is Mental deterioration.